首页 > 最新文献

JSLS : Journal of the Society of Laparoendoscopic Surgeons最新文献

英文 中文
Comparison of General Anesthesia and Combined Spinal and Epidural Anesthesia for Gasless Laparoscopic Surgery in Gynecology. 全身麻醉与脊髓硬膜外联合麻醉在妇科无气腹腔镜手术中的比较。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2022-04-01 DOI: 10.4293/JSLS.2022.00004
Jong Ha Hwang, Bo Wook Kim

Background and objectives: Laparoscopic surgeries in gynecologic field have been performed under general anesthesia (GA) due to the respiratory changes caused by pneumoperitoneum and Trendelenburg position. Therefore, this study aimed to compared general anesthesia and combined spinal and epidural anesthesia (CSEA) for gasless laparoscopic surgery in gynecologic field.

Methods: We matched patients with type of surgery who underwent gasless single port access (SPA) laparoscopic surgery under general anesthesia and CSEA. The medical records of 90 patients between March 1, 2018 and June 30, 2020 were reviewed. Gasless laparoscopic surgery was performed in all patients with a SPA using a J-shaped retractor.

Results: No significant differences were observed for age, body mass index, parity, and previous abdominal surgery between GA and CSEA groups. During operation under CSEA, six patients (20%) experienced nausea/vomiting. Hypotension (systolic blood pressure < 90 mmHg) was observed in five patients (16.7%). Intravenous analgesics was administrated in four of the patients (13.3%) who suffered from shoulder pain or abdominal discomfort. One patient developed bradycardia. The duration of hospital admission was shorter in the CSEA group than in the GA group (p = 0.014). There was no difference between the groups in terms of surgery type, surgical specific finding, operation time, estimated blood loss, laparotomy conversion rate and use of additional trocar. No major complications such as urologic, bowel, or vessel injuries were found in both groups.

Conclusions: CSEA is a safe and feasible technique for application in nonobese patients undergoing gasless laparoscopic surgery in gynecologic field.

背景与目的:由于气腹和Trendelenburg体位引起的呼吸变化,妇科腹腔镜手术在全麻下进行。因此,本研究旨在比较全身麻醉与脊髓硬膜外联合麻醉(CSEA)在妇科无气腹腔镜手术中的应用。方法:我们将不同手术类型的患者在全麻和CSEA下进行无气腹单孔通道(SPA)腹腔镜手术。查阅了2018年3月1日至2020年6月30日90例患者的病历。使用j型牵开器对所有SPA患者进行无气腹腹腔镜手术。结果:GA组和CSEA组在年龄、体重指数、胎次和既往腹部手术方面无显著差异。在CSEA下手术期间,6例(20%)患者出现恶心/呕吐。低血压(收缩压p = 0.014)。两组在手术类型、手术特异性发现、手术时间、估计出血量、开腹转换率和额外套管针使用方面无差异。两组均无重大并发症,如泌尿系统、肠道或血管损伤。结论:CSEA技术在妇科非肥胖患者无气腹腔镜手术中应用安全可行。
{"title":"Comparison of General Anesthesia and Combined Spinal and Epidural Anesthesia for Gasless Laparoscopic Surgery in Gynecology.","authors":"Jong Ha Hwang,&nbsp;Bo Wook Kim","doi":"10.4293/JSLS.2022.00004","DOIUrl":"https://doi.org/10.4293/JSLS.2022.00004","url":null,"abstract":"<p><strong>Background and objectives: </strong>Laparoscopic surgeries in gynecologic field have been performed under general anesthesia (GA) due to the respiratory changes caused by pneumoperitoneum and Trendelenburg position. Therefore, this study aimed to compared general anesthesia and combined spinal and epidural anesthesia (CSEA) for gasless laparoscopic surgery in gynecologic field.</p><p><strong>Methods: </strong>We matched patients with type of surgery who underwent gasless single port access (SPA) laparoscopic surgery under general anesthesia and CSEA. The medical records of 90 patients between March 1, 2018 and June 30, 2020 were reviewed. Gasless laparoscopic surgery was performed in all patients with a SPA using a J-shaped retractor.</p><p><strong>Results: </strong>No significant differences were observed for age, body mass index, parity, and previous abdominal surgery between GA and CSEA groups. During operation under CSEA, six patients (20%) experienced nausea/vomiting. Hypotension (systolic blood pressure < 90 mmHg) was observed in five patients (16.7%). Intravenous analgesics was administrated in four of the patients (13.3%) who suffered from shoulder pain or abdominal discomfort. One patient developed bradycardia. The duration of hospital admission was shorter in the CSEA group than in the GA group (<i>p</i> = 0.014). There was no difference between the groups in terms of surgery type, surgical specific finding, operation time, estimated blood loss, laparotomy conversion rate and use of additional trocar. No major complications such as urologic, bowel, or vessel injuries were found in both groups.</p><p><strong>Conclusions: </strong>CSEA is a safe and feasible technique for application in nonobese patients undergoing gasless laparoscopic surgery in gynecologic field.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/41/e2022.00004.PMC9215695.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40492512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Liposomal Bupivacaine Injection for Analgesia During Minimally Invasive Supracervical Hysterectomy. 布比卡因脂质体注射在微创宫颈上子宫切除术中的镇痛作用。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2022-04-01 DOI: 10.4293/JSLS.2022.00008
Mary Ann Son, Shantel Jiggetts, Amro Elfeky, Camila De Amorim Paiva, Michael Silver, David Herzog, Sumit Saraf, Pedram Bral

Objective: To evaluate the efficacy of intracervical injection of liposomal bupivacaine for postoperative pain control among women undergoing minimally invasive supracervical hysterectomy.

Methods: A randomized double-blinded placebo-controlled trial of intracervical injection of combination liposomal bupivacaine and bupivacaine for postoperative pain among patients undergoing laparoscopic and robotic supracervical hysterectomy. Patients were enrolled between October 1, 2018 and April 30, 2019. The primary outcome was pain at 12 hours postoperatively using a numeric rating scale from zero to 10. Pain scores were also recorded pre-operatively, immediately postoperatively, at 12, 24, and 48 hours postoperatively. The secondary outcome was the number of patients who required opioid analgesic medications up to 48 hours postoperatively.

Results: Sixty participants were randomized into the control (n = 30) and intervention (n = 30) groups. Pain scores were 1 and 1.75 (p = 0.89) immediately postoperatively, 3 and 3.5 (p = 0.85) at 12 hours, 3.5 and 5 (p = 0.22) at 24 hours, and 2.75 and 4 (p = 0.18) at 48 hours for the control and intervention groups, respectively. Within the first 24 hours, 10 patients in the control and 14 patients in the intervention group used narcotics (p = 0.37). From the 24 to 48 hours window, 6 and 8 patients in the control and intervention groups used narcotics (p = 0.74), respectively.

Conclusion: There was no statistically significant difference in pain scores between patients receiving combination liposomal bupivacaine and bupivacaine intracervical block and those receiving placebo in the first 48 hours after surgery. There was no difference in analgesic use between the two study groups.

目的:评价宫颈内注射布比卡因脂质体对微创宫颈上子宫切除术妇女术后疼痛的控制效果。方法:采用随机双盲安慰剂对照试验,对腹腔镜和机器人宫颈上子宫切除术患者进行宫颈内注射布比卡因联合脂质体和布比卡因治疗术后疼痛。患者在2018年10月1日至2019年4月30日期间入组。主要结果是术后12小时的疼痛,使用从0到10的数字评分量表。同时记录术前、术后即刻、术后12、24、48小时疼痛评分。次要结果是术后48小时内需要阿片类镇痛药物的患者数量。结果:60名受试者随机分为对照组(n = 30)和干预组(n = 30)。对照组和干预组术后即刻疼痛评分分别为1分和1.75分(p = 0.89), 12小时疼痛评分分别为3分和3.5分(p = 0.85), 24小时疼痛评分分别为3.5分和5分(p = 0.22), 48小时疼痛评分分别为2.75分和4分(p = 0.18)。治疗前24小时内,对照组10例,干预组14例使用麻醉品(p = 0.37)。在24 ~ 48小时内,对照组和干预组分别有6例和8例患者使用麻醉品(p = 0.74)。结论:术后48小时内,布比卡因联合脂质体和布比卡因颈内阻滞组与安慰剂组疼痛评分差异无统计学意义。两个研究组在镇痛药的使用上没有差异。
{"title":"Liposomal Bupivacaine Injection for Analgesia During Minimally Invasive Supracervical Hysterectomy.","authors":"Mary Ann Son,&nbsp;Shantel Jiggetts,&nbsp;Amro Elfeky,&nbsp;Camila De Amorim Paiva,&nbsp;Michael Silver,&nbsp;David Herzog,&nbsp;Sumit Saraf,&nbsp;Pedram Bral","doi":"10.4293/JSLS.2022.00008","DOIUrl":"https://doi.org/10.4293/JSLS.2022.00008","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy of intracervical injection of liposomal bupivacaine for postoperative pain control among women undergoing minimally invasive supracervical hysterectomy.</p><p><strong>Methods: </strong>A randomized double-blinded placebo-controlled trial of intracervical injection of combination liposomal bupivacaine and bupivacaine for postoperative pain among patients undergoing laparoscopic and robotic supracervical hysterectomy. Patients were enrolled between October 1, 2018 and April 30, 2019. The primary outcome was pain at 12 hours postoperatively using a numeric rating scale from zero to 10. Pain scores were also recorded pre-operatively, immediately postoperatively, at 12, 24, and 48 hours postoperatively. The secondary outcome was the number of patients who required opioid analgesic medications up to 48 hours postoperatively.</p><p><strong>Results: </strong>Sixty participants were randomized into the control (n = 30) and intervention (n = 30) groups. Pain scores were 1 and 1.75 (p = 0.89) immediately postoperatively, 3 and 3.5 (p = 0.85) at 12 hours, 3.5 and 5 (p = 0.22) at 24 hours, and 2.75 and 4 (p = 0.18) at 48 hours for the control and intervention groups, respectively. Within the first 24 hours, 10 patients in the control and 14 patients in the intervention group used narcotics (p = 0.37). From the 24 to 48 hours window, 6 and 8 patients in the control and intervention groups used narcotics (p = 0.74), respectively.</p><p><strong>Conclusion: </strong>There was no statistically significant difference in pain scores between patients receiving combination liposomal bupivacaine and bupivacaine intracervical block and those receiving placebo in the first 48 hours after surgery. There was no difference in analgesic use between the two study groups.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/b7/e2022.00008.PMC9255262.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40492048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Strategies and Outcomes of Total Laparoscopic Hysterectomy for Large Uterine Cervical Fibroids. 腹腔镜下全子宫切除术治疗大子宫颈肌瘤的策略与效果。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00031
Fumiaki Taniguchi

Background and objectives: To present the methods and outcomes of total laparoscopic hysterectomy with debulking surgery for large cervical fibroids.

Methods: This is a single-center study. Twenty-one women who underwent total laparoscopic hysterectomy between October 1, 2012 and November 30, 2020 for large cervical fibroids (diameter ≥10 cm) based on a diagnosis by magnetic resonance imagining were enrolled. Conventional total laparoscopic hysterectomy for large cervical fibroids was initially attempted. If this could not be completed, debulking surgery, such as enucleation of large cervical fibroids or cervical amputation, was performed during total laparoscopic hysterectomy.

Results: Total laparoscopic hysterectomy could be completed in all 21 patients with large cervical fibroids without blood transfusion. Conventional total laparoscopic hysterectomy was performed in four patients (19%), and 17 patients (81%) required debulking surgery at the time of total laparoscopic hysterectomy. The median diameter of the major axis of the cervical fibroid, uterine weight, intraoperative blood loss, and operative time were 12 cm, 750 g, 100 mL, and 191 min, respectively.

Conclusion: Total laparoscopic hysterectomy for large cervical fibroids, although minimally invasive, requires a high level of laparoscopic skill. However, our data suggests that total laparoscopic hysterectomy for large cervical fibroids can be feasible, with an acceptable level of blood loss, by performing debulking surgeries such as enucleation of large cervical fibroids or cervical amputation.

背景与目的:介绍腹腔镜下大子宫肌瘤全子宫切除术的方法和效果。方法:这是一项单中心研究。在2012年10月1日至2020年11月30日期间,21名女性接受了全腹腔镜子宫切除术,这些女性是基于磁共振成像诊断的大宫颈肌瘤(直径≥10cm)。传统的腹腔镜全子宫切除术用于大的宫颈肌瘤的最初尝试。如果不能完成,则在腹腔镜全子宫切除术期间进行减体积手术,如大宫颈肌瘤去核或宫颈截肢。结果:21例宫颈大肌瘤患者均可在不输血的情况下完成腹腔镜全子宫切除术。4例(19%)患者行常规腹腔镜全子宫切除术,17例(81%)患者在行腹腔镜全子宫切除术时需行减体积手术。宫颈肌瘤长轴中位直径12 cm,子宫重量750 g,术中出血量100 mL,手术时间191 min。结论:腹腔镜下大肌瘤全子宫切除术虽然微创,但需要高水平的腹腔镜技术。然而,我们的数据表明,在可接受的失血量水平下,通过实施减体积手术(如大宫颈肌瘤去核或宫颈截肢),腹腔镜下大宫颈肌瘤全子宫切除术是可行的。
{"title":"Strategies and Outcomes of Total Laparoscopic Hysterectomy for Large Uterine Cervical Fibroids.","authors":"Fumiaki Taniguchi","doi":"10.4293/JSLS.2021.00031","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00031","url":null,"abstract":"<p><strong>Background and objectives: </strong>To present the methods and outcomes of total laparoscopic hysterectomy with debulking surgery for large cervical fibroids.</p><p><strong>Methods: </strong>This is a single-center study. Twenty-one women who underwent total laparoscopic hysterectomy between October 1, 2012 and November 30, 2020 for large cervical fibroids (diameter ≥10 cm) based on a diagnosis by magnetic resonance imagining were enrolled. Conventional total laparoscopic hysterectomy for large cervical fibroids was initially attempted. If this could not be completed, debulking surgery, such as enucleation of large cervical fibroids or cervical amputation, was performed during total laparoscopic hysterectomy.</p><p><strong>Results: </strong>Total laparoscopic hysterectomy could be completed in all 21 patients with large cervical fibroids without blood transfusion. Conventional total laparoscopic hysterectomy was performed in four patients (19%), and 17 patients (81%) required debulking surgery at the time of total laparoscopic hysterectomy. The median diameter of the major axis of the cervical fibroid, uterine weight, intraoperative blood loss, and operative time were 12 cm, 750 g, 100 mL, and 191 min, respectively.</p><p><strong>Conclusion: </strong>Total laparoscopic hysterectomy for large cervical fibroids, although minimally invasive, requires a high level of laparoscopic skill. However, our data suggests that total laparoscopic hysterectomy for large cervical fibroids can be feasible, with an acceptable level of blood loss, by performing debulking surgeries such as enucleation of large cervical fibroids or cervical amputation.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a3/f2/e2021.00031.PMC8603400.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39806368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Does Transverse Abdominis Plane Block Increase the Risk of Postoperative Urinary Retention after Inguinal Hernia Repair? 腹股沟疝修补术后横腹面阻滞是否增加尿潴留的风险?
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00015
Rene Aleman, David Gutierrez Blanco, David Romero Funes, Lisandro Montorfano, George Semien, Samuel Szomstein, Emanuele Lo Menzo, Raul J Rosenthal

Background and objective: Postoperative urinary retention (POUR) is a common adverse event after inguinal hernia repair (IHR), with an incidence of up to 22.2%. The aim of this study is to determine if pre-operative transverse abdominis plane (TAP) block increases the incidence of POUR.

Methods: A retrospective review was performed for all patients who underwent IHR (open or laparoscopic) at this institution, from January 1, 2016 to December 31, 2017. Patients were divided into two groups: Patients that had a TAP block before surgery (group 1) and patients with no TAP block (group 2). Common demographics and comorbidities were collected along with postoperative outcomes and POUR incidence rates for every group to determine procedural influence.

Results: From 276 patients reviewed, 28.2% (N = 78) underwent TAP block before surgery. The patient cohort mean age was 61.1 ± 14.4 years. Most the interventions were laparoscopic (81.2%) and an overall POUR incidence rate of 7.6% (N = 21) was observed. Comparatively, common demographics and comorbidities were statistically similar for both groups, with the exception of type 2 diabetes mellitus (p =0.049). Individually, group 1 and 2 presented POUR incidence rates of 14.1% and 5.05%, respectively. While intraoperative fluid administration, early readmission rate, and length were similar in both groups, there was a significant difference in POUR incidence rates (p =0.01).

Conclusion: Patients undergoing TAP block during IHR might have an increased risk of developing POUR. Further larger, prospective, and randomized controlled studies are necessary to better assess these findings.

背景与目的:术后尿潴留(POUR)是腹股沟疝修补术(IHR)后常见的不良事件,发生率高达22.2%。本研究的目的是确定术前横腹平面(TAP)阻滞是否会增加POUR的发生率。方法:回顾性分析2016年1月1日至2017年12月31日在该机构接受IHR(开放式或腹腔镜)治疗的所有患者。患者被分为两组:术前有TAP阻断的患者(1组)和无TAP阻断的患者(2组)。收集每组的常见人口统计数据和合并症以及术后结果和POUR发生率,以确定手术影响。结果:276例患者中,28.2% (N = 78)术前接受了TAP阻滞。患者队列平均年龄为61.1±14.4岁。大多数干预措施为腹腔镜(81.2%),总体POUR发生率为7.6% (N = 21)。相比之下,除了2型糖尿病外,两组的常见人口统计学和合并症在统计学上相似(p = 0.049)。单独来看,1组和2组的POUR发病率分别为14.1%和5.05%。两组术中给液量、早期再入院率和住院时间相似,但POUR发生率差异有统计学意义(p = 0.01)。结论:在IHR期间接受TAP阻断的患者可能增加发生POUR的风险。为了更好地评估这些发现,需要进一步的更大规模、前瞻性和随机对照研究。
{"title":"Does Transverse Abdominis Plane Block Increase the Risk of Postoperative Urinary Retention after Inguinal Hernia Repair?","authors":"Rene Aleman,&nbsp;David Gutierrez Blanco,&nbsp;David Romero Funes,&nbsp;Lisandro Montorfano,&nbsp;George Semien,&nbsp;Samuel Szomstein,&nbsp;Emanuele Lo Menzo,&nbsp;Raul J Rosenthal","doi":"10.4293/JSLS.2021.00015","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00015","url":null,"abstract":"<p><strong>Background and objective: </strong>Postoperative urinary retention (POUR) is a common adverse event after inguinal hernia repair (IHR), with an incidence of up to 22.2%. The aim of this study is to determine if pre-operative transverse abdominis plane (TAP) block increases the incidence of POUR.</p><p><strong>Methods: </strong>A retrospective review was performed for all patients who underwent IHR (open or laparoscopic) at this institution, from January 1, 2016 to December 31, 2017. Patients were divided into two groups: Patients that had a TAP block before surgery (group 1) and patients with no TAP block (group 2). Common demographics and comorbidities were collected along with postoperative outcomes and POUR incidence rates for every group to determine procedural influence.</p><p><strong>Results: </strong>From 276 patients reviewed, 28.2% (N = 78) underwent TAP block before surgery. The patient cohort mean age was 61.1 ± 14.4 years. Most the interventions were laparoscopic (81.2%) and an overall POUR incidence rate of 7.6% (N = 21) was observed. Comparatively, common demographics and comorbidities were statistically similar for both groups, with the exception of type 2 diabetes mellitus (<i>p </i>=<i> </i>0.049). Individually, group 1 and 2 presented POUR incidence rates of 14.1% and 5.05%, respectively. While intraoperative fluid administration, early readmission rate, and length were similar in both groups, there was a significant difference in POUR incidence rates (<i>p </i>=<i> </i>0.01).</p><p><strong>Conclusion: </strong>Patients undergoing TAP block during IHR might have an increased risk of developing POUR. Further larger, prospective, and randomized controlled studies are necessary to better assess these findings.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/86/17/e2021.00015.PMC8580164.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39642926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Vault Endometriosis: Detailed Step-by-Step Laparoscopic Surgical Management Technique. 拱顶子宫内膜异位症:详细的逐步腹腔镜手术管理技术。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00057
Dipak Limbachiya, Rajnish Tiwari, Rashmi Kumari

Background and objectives: The aim of this study was to demonstrate a detailed and elaborative step-wise laparoscopic surgical management technique of vault endometriosis.

Methods: A total of 5 patients were operated on for laparoscopic management of vault endometriosis performed at our center between January 1 2015 and December 31, 2019.

Results: There were no short or long term complications related to laparoscopic management of vault endometriosis with a satisfactory prognosis.

Conclusion: This analysis explains the descriptive methodology of assessment of patients and operative technique for vault endometriosis.

背景和目的:本研究的目的是展示一种详细和详细的渐进式腹腔镜手术治疗穹窿子宫内膜异位症的技术。方法:选取2015年1月1日至2019年12月31日在我中心行腹腔镜治疗穹窿子宫内膜异位症患者5例。结果:腹腔镜治疗穹窿子宫内膜异位症无短期或长期并发症,预后满意。结论:本分析解释了穹窿子宫内膜异位症患者评估的描述性方法和手术技术。
{"title":"Vault Endometriosis: Detailed Step-by-Step Laparoscopic Surgical Management Technique.","authors":"Dipak Limbachiya,&nbsp;Rajnish Tiwari,&nbsp;Rashmi Kumari","doi":"10.4293/JSLS.2021.00057","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00057","url":null,"abstract":"<p><strong>Background and objectives: </strong>The aim of this study was to demonstrate a detailed and elaborative step-wise laparoscopic surgical management technique of vault endometriosis.</p><p><strong>Methods: </strong>A total of 5 patients were operated on for laparoscopic management of vault endometriosis performed at our center between January 1 2015 and December 31, 2019.</p><p><strong>Results: </strong>There were no short or long term complications related to laparoscopic management of vault endometriosis with a satisfactory prognosis.</p><p><strong>Conclusion: </strong>This analysis explains the descriptive methodology of assessment of patients and operative technique for vault endometriosis.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c1/39/e2021.00057.PMC8580167.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39642925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
To Wrap or Not to Wrap After Heller Myotomy. 海勒肌切开术后,是否要包扎。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00054
Muhammad B Darwish, Shankar I Logarajah, Kei Nagatomo, Terence Jackson, Annie Laurie Benzie, Patrick James McLaren, Edward Cho, Houssam Osman, D Rohan Jeyarajah

Background and objectives: The primary aim of this study is to assess the necessity of fundoplication for reflux in patients undergoing Heller myotomy for achalasia. The secondary aim is to assess the safety of the robotic approach to Heller myotomy.

Methods: This is a single institution, retrospective analysis of 61 patients who underwent robotic Heller myotomy with or without fundoplication over a 4-year period (January 1, 2015 - December 31, 2019). Symptoms were evaluated using pre-operative and postoperative Eckardt scores at < 2 weeks (short-term) and 4 - 55 months (long-term) postoperatively. Incidence of gastroesophageal reflux and use of antacids postoperatively were assessed. Long-term patient satisfaction and quality of life (QOL) were assessed with a phone survey. Finally, the perioperative safety profile of robotic Heller myotomy was evaluated.

Results: The long-term average Eckardt score in patients undergoing Heller myotomy without fundoplication was notably lower than in patients with a fundoplication (0.72 vs 2.44). Gastroesophageal reflux rates were lower in patient without a fundoplication (16.0% vs 33.3%). Additionally, dysphagia rates were lower in patients without a fundoplication (32.0% vs 44.4%). Only 34.8% (8/25) of patients without fundoplication continued use of antacids in the long-term. There were no mortalities and a 4.2% complication rate with two delayed leaks.

Conclusion: Robotic Heller myotomy without fundoplication is safe and effective for achalasia. The rate of reflux symptoms and overall Eckardt scores were low postoperatively. Great patient satisfaction and QOL were observed in the long term. Our results suggest that fundoplication is unnecessary when performing Heller myotomy.

背景和目的:本研究的主要目的是评估接受Heller肌切开术治疗贲门失弛缓症患者反流的必要性。第二个目的是评估机器人入路海勒肌切开术的安全性。方法:这是一项单一机构的回顾性分析,在4年期间(2015年1月1日至2019年12月31日),61名患者接受了机器人Heller肌切开术,伴有或不伴有眼底复制。在术后< 2周(短期)和4 - 55个月(长期)使用术前和术后Eckardt评分评估症状。评估胃食管反流发生率及术后抗酸药使用情况。通过电话调查评估患者的长期满意度和生活质量。最后,对机器人Heller肌切开术的围手术期安全性进行评价。结果:行Heller肌切开术无底重复患者的长期平均Eckardt评分明显低于有底重复患者(0.72 vs 2.44)。胃食管反流率在没有胃底重叠的患者中较低(16.0% vs 33.3%)。此外,没有基底部复制的患者的吞咽困难发生率较低(32.0% vs 44.4%)。只有34.8%(8/25)的无底溃患者继续长期使用抗酸药。无死亡,2例迟发性漏的并发症发生率为4.2%。结论:机器人Heller肌切开术治疗贲门失弛缓症安全有效。术后反流症状发生率和总Eckardt评分均较低。长期观察患者满意度和生活质量。我们的结果表明,在进行Heller肌切开术时,不需要重复眼底。
{"title":"To Wrap or Not to Wrap After Heller Myotomy.","authors":"Muhammad B Darwish,&nbsp;Shankar I Logarajah,&nbsp;Kei Nagatomo,&nbsp;Terence Jackson,&nbsp;Annie Laurie Benzie,&nbsp;Patrick James McLaren,&nbsp;Edward Cho,&nbsp;Houssam Osman,&nbsp;D Rohan Jeyarajah","doi":"10.4293/JSLS.2021.00054","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00054","url":null,"abstract":"<p><strong>Background and objectives: </strong>The primary aim of this study is to assess the necessity of fundoplication for reflux in patients undergoing Heller myotomy for achalasia. The secondary aim is to assess the safety of the robotic approach to Heller myotomy.</p><p><strong>Methods: </strong>This is a single institution, retrospective analysis of 61 patients who underwent robotic Heller myotomy with or without fundoplication over a 4-year period (January 1, 2015 - December 31, 2019). Symptoms were evaluated using pre-operative and postoperative Eckardt scores at < 2 weeks (short-term) and 4 - 55 months (long-term) postoperatively. Incidence of gastroesophageal reflux and use of antacids postoperatively were assessed. Long-term patient satisfaction and quality of life (QOL) were assessed with a phone survey. Finally, the perioperative safety profile of robotic Heller myotomy was evaluated.</p><p><strong>Results: </strong>The long-term average Eckardt score in patients undergoing Heller myotomy without fundoplication was notably lower than in patients with a fundoplication (0.72 vs 2.44). Gastroesophageal reflux rates were lower in patient without a fundoplication (16.0% vs 33.3%). Additionally, dysphagia rates were lower in patients without a fundoplication (32.0% vs 44.4%). Only 34.8% (8/25) of patients without fundoplication continued use of antacids in the long-term. There were no mortalities and a 4.2% complication rate with two delayed leaks.</p><p><strong>Conclusion: </strong>Robotic Heller myotomy without fundoplication is safe and effective for achalasia. The rate of reflux symptoms and overall Eckardt scores were low postoperatively. Great patient satisfaction and QOL were observed in the long term. Our results suggest that fundoplication is unnecessary when performing Heller myotomy.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/1f/e2021.00054.PMC8580166.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39643382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Location of Hemangioma is an Individual Risk Factor for Massive Bleeding in Laparoscopic Hepatectomy. 血管瘤的位置是腹腔镜肝切除术大出血的个体危险因素。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00070
Shuang Si, Liguo Liu, Jia Huang, Yongliang Sun, Xiaolei Liu, Li Xu, Wenying Zhou, Haidong Tan, Zhiying Yang Md

Background and objectives: The scope of laparoscopic surgery has expanded to encompass hepatic resections, specifically hepatic hemangioma. The most serious intraoperative complication is bleeding, often requiring laparotomy. Because risk factors associated with such massive blood loss have not been well evaluated, the intent of this retrospective study was to analyze these risk factors associated with laparoscopic resection of hepatic hemangiomas.

Methods: From June 1, 2011 to January 31, 2021, 140 consecutive patients underwent laparoscopic surgery for hepatic hemangioma in our hospital. According to quantity of intraoperative blood loss, they were divided into massive (≥ 800 ml) and minor blood loss (< 800 ml) groups. Perioperative data were analyzed by univariate and multivariate analyses with logistic regression to identify the risk factors for potential massive blood loss during laparoscopic resection.

Results: There were 24 and 116 patients in the massive and minor blood loss groups, respectively. Of four risk factors significantly associated with massive blood loss by univariate logistic regression analysis (location of hemangioma in the liver, postcaval or hepatic venous compression, hilar compression, and body mass index exceeding 28) the multifactorial logistic model identified only location in the liver of the hemangioma as statistically (P = 0.012) associated with intraoperative massive blood loss.

Conclusions: Location of the hepatic hemangioma was the single statistically significant risk factor for massive blood loss during laparoscopic surgery for hepatic hemangioma. Of particular importance, location in Couinaud liver segments I, IVa, VII, and VIII necessitates precautions to mitigate the risk of massive blood loss.

背景和目的:腹腔镜手术的范围已经扩展到肝切除,特别是肝血管瘤。最严重的术中并发症是出血,通常需要开腹手术。由于与如此大量失血相关的危险因素尚未得到很好的评估,因此本回顾性研究的目的是分析腹腔镜肝血管瘤切除术相关的危险因素。方法:2011年6月1日至2021年1月31日,我院连续140例肝血管瘤患者行腹腔镜手术治疗。根据术中出血量分为大量出血量(≥800 ml)和少量出血量(< 800 ml)组。采用单因素和多因素logistic回归分析围手术期资料,以确定腹腔镜切除术中潜在大出血的危险因素。结果:大量失血量组24例,少量失血量组116例。通过单因素logistic回归分析,在与大出血显著相关的4个危险因素(肝血管瘤位置、腔静脉后或肝静脉压迫、肝门压迫和体重指数超过28)中,多因素logistic模型发现,只有肝血管瘤位置与术中大出血有统计学意义(P = 0.012)。结论:肝血管瘤的位置是腹腔镜肝血管瘤手术中大量失血的单一有统计学意义的危险因素。特别重要的是,它位于库伊诺肝I、IVa、VII和VIII节段,需要采取预防措施,以减轻大量失血的风险。
{"title":"Location of Hemangioma is an Individual Risk Factor for Massive Bleeding in Laparoscopic Hepatectomy.","authors":"Shuang Si,&nbsp;Liguo Liu,&nbsp;Jia Huang,&nbsp;Yongliang Sun,&nbsp;Xiaolei Liu,&nbsp;Li Xu,&nbsp;Wenying Zhou,&nbsp;Haidong Tan,&nbsp;Zhiying Yang Md","doi":"10.4293/JSLS.2021.00070","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00070","url":null,"abstract":"<p><strong>Background and objectives: </strong>The scope of laparoscopic surgery has expanded to encompass hepatic resections, specifically hepatic hemangioma. The most serious intraoperative complication is bleeding, often requiring laparotomy. Because risk factors associated with such massive blood loss have not been well evaluated, the intent of this retrospective study was to analyze these risk factors associated with laparoscopic resection of hepatic hemangiomas.</p><p><strong>Methods: </strong>From June 1, 2011 to January 31, 2021, 140 consecutive patients underwent laparoscopic surgery for hepatic hemangioma in our hospital. According to quantity of intraoperative blood loss, they were divided into massive (≥ 800 ml) and minor blood loss (< 800 ml) groups. Perioperative data were analyzed by univariate and multivariate analyses with logistic regression to identify the risk factors for potential massive blood loss during laparoscopic resection.</p><p><strong>Results: </strong>There were 24 and 116 patients in the massive and minor blood loss groups, respectively. Of four risk factors significantly associated with massive blood loss by univariate logistic regression analysis (location of hemangioma in the liver, postcaval or hepatic venous compression, hilar compression, and body mass index exceeding 28) the multifactorial logistic model identified only location in the liver of the hemangioma as statistically (P = 0.012) associated with intraoperative massive blood loss.</p><p><strong>Conclusions: </strong>Location of the hepatic hemangioma was the single statistically significant risk factor for massive blood loss during laparoscopic surgery for hepatic hemangioma. Of particular importance, location in Couinaud liver segments I, IVa, VII, and VIII necessitates precautions to mitigate the risk of massive blood loss.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/5b/e2021.00070.PMC8678761.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39759322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Predictors of Minimally Invasive Myomectomy in the National Inpatient Sample Database, 2010-2014. 2010-2014年全国住院患者样本数据库中微创子宫肌瘤切除术的预测因素
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00065
Anja S Frost, Meghan McMahon, Anna Jo Bodurtha Smith, Mostafa A Borahay, Kristin E Patzkowsky

Background and objectives: This study aims to characterize the utilization of minimally invasive myomectomy in the United States and to identify the patient and hospital factors associated with surgical approach to myomectomy.

Methods: This is a cross-sectional study using the National Inpatient Sample database. We extracted women aged 18-50 years who underwent open and minimally invasive (laparoscopic and robotic) myomectomy (MIM) from January 1, 2010-December 31, 2014. Descriptive statistics were obtained for patient and hospital characteristics. We then performed multivariable logistic regression to examine the association of patient (age, race, insurance status, median household income) and hospital (bed size, teaching status, for-profit status, census region, cases volume) characteristics with the likelihood of undergoing MIM.

Results: Of 114,850 myomectomy cases, 8,330 (7%) underwent MIM and 106,520 (93%) were open. Over time, the proportion of MIM remained very low and slightly decreased from 8.2% in 2010 to 6.1% in 2014 (p-for-trend: 0.001). Most hospitals performed few MIM per year, with 50% performing five or less, and 25% performing three or fewer per year. African American, Hispanic, and women of other races were less likely to undergo MIM compared to Caucasian women (adjusted odds ration [OR] 0.57, 95% confidence interval [CI] 0.50-0.64; 0.71, 95% CI 0.60-0.83; 0.62, 95% CI 0.52-0.74, respectively). Women in the West (adjusted odds ratio (aOR) 1.23, 95% CI 1.04-1.46) and Midwest (aOR 1.27, 95% CI 1.07-1.52) had higher odds of undergoing MIM.

Conclusion: MIM appears to be an underutilized modality, accounting for less than10% of myomectomies. This underutilization disproportionally affects minority women.

背景和目的:本研究旨在描述微创子宫肌瘤切除术在美国的应用情况,并确定与子宫肌瘤切除术手术入路相关的患者和医院因素。方法:这是一个使用国家住院病人样本数据库的横断面研究。我们选取了2010年1月1日至2014年12月31日期间接受开放和微创(腹腔镜和机器人)子宫肌瘤切除术(MIM)的18-50岁女性。对患者和医院特征进行描述性统计。然后,我们进行多变量logistic回归,以检验患者(年龄、种族、保险状况、家庭收入中位数)和医院(床位大小、教学状况、营利性状况、人口普查地区、病例量)特征与接受MIM可能性的关系。结果:114850例子宫肌瘤切除术中,8330例(7%)行MIM, 106520例(93%)为切开。随着时间的推移,MIM的比例仍然很低,从2010年的8.2%略微下降到2014年的6.1%(趋势p值:0.001)。大多数医院每年进行的MIM很少,50%的医院每年进行5次或更少,25%的医院每年进行3次或更少。与白人女性相比,非裔美国人、西班牙裔和其他种族的女性更不可能经历MIM(调整优势比[OR] 0.57, 95%可信区间[CI] 0.50-0.64;0.71, 95% ci 0.60-0.83;0.62, 95% CI分别为0.52-0.74)。西部妇女(调整优势比(aOR) 1.23, 95% CI 1.04-1.46)和中西部妇女(aOR 1.27, 95% CI 1.07-1.52)接受MIM的几率较高。结论:MIM似乎是一种未充分利用的方式,占子宫肌瘤切除术的不到10%。这种利用不足对少数民族妇女的影响尤为严重。
{"title":"Predictors of Minimally Invasive Myomectomy in the National Inpatient Sample Database, 2010-2014.","authors":"Anja S Frost,&nbsp;Meghan McMahon,&nbsp;Anna Jo Bodurtha Smith,&nbsp;Mostafa A Borahay,&nbsp;Kristin E Patzkowsky","doi":"10.4293/JSLS.2021.00065","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00065","url":null,"abstract":"<p><strong>Background and objectives: </strong>This study aims to characterize the utilization of minimally invasive myomectomy in the United States and to identify the patient and hospital factors associated with surgical approach to myomectomy.</p><p><strong>Methods: </strong>This is a cross-sectional study using the National Inpatient Sample database. We extracted women aged 18-50 years who underwent open and minimally invasive (laparoscopic and robotic) myomectomy (MIM) from January 1, 2010-December 31, 2014. Descriptive statistics were obtained for patient and hospital characteristics. We then performed multivariable logistic regression to examine the association of patient (age, race, insurance status, median household income) and hospital (bed size, teaching status, for-profit status, census region, cases volume) characteristics with the likelihood of undergoing MIM.</p><p><strong>Results: </strong>Of 114,850 myomectomy cases, 8,330 (7%) underwent MIM and 106,520 (93%) were open. Over time, the proportion of MIM remained very low and slightly decreased from 8.2% in 2010 to 6.1% in 2014 (p-for-trend: 0.001). Most hospitals performed few MIM per year, with 50% performing five or less, and 25% performing three or fewer per year. African American, Hispanic, and women of other races were less likely to undergo MIM compared to Caucasian women (adjusted odds ration [OR] 0.57, 95% confidence interval [CI] 0.50-0.64; 0.71, 95% CI 0.60-0.83; 0.62, 95% CI 0.52-0.74, respectively). Women in the West (adjusted odds ratio (aOR) 1.23, 95% CI 1.04-1.46) and Midwest (aOR 1.27, 95% CI 1.07-1.52) had higher odds of undergoing MIM.</p><p><strong>Conclusion: </strong>MIM appears to be an underutilized modality, accounting for less than10% of myomectomies. This underutilization disproportionally affects minority women.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/57/e2021.00065.PMC8764897.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39866372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of COVID-19 Response and Impact on Gynecologic Surgery at a Large Academic Hospital System. 某大型学术医院系统新型冠状病毒肺炎应对及对妇科外科的影响分析
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00056
Shabnam Gupta, Parmida Maghsoudlou, Mobolaji Ajao, Jon Ivar Einarsson, Louise Perkins King

Background and objectives: The COVID-19 pandemic dramatically impacted gynecologic surgery. In March 2020, the American College of Surgeons recommended delay of all nonessential invasive procedures. This study characterizes the number and types of procedures performed during the peak pandemic.

Methods: A retrospective cohort study was performed. All patients undergoing gynecological surgery at a large academic hospital system from March 16, 2019 to July 31, 2019 and from March 16, 2020 to July 31, 2020 were evaluated. Data was stratified by three time periods corresponding to state and hospital policy changes. During period 1, no nonessential procedures were advised. During period 2, urgent procedures resumed. During period 3, full surgical reopening was achieved.

Results: In 2019, 1,545 gynecologic cases were performed compared with 942 cases in 2020 (39.0% decrease). There was a 73.6% decrease in cases over period 1, a 20.1% decrease over period 2, and a 2.9% increase over period 3. Cases performed by gynecologic oncologists in 2020 accounted for 58.1% of all gynecologic cases over period 1, 29.4% of cases over period 2, and 33.3% of cases over period 3. In 2020, hysterectomy was the most commonly performed procedure, while surgery for endometriosis and uterine fibroids had the greatest decrease in volume. Among emergency procedures, more surgery for ectopic pregnancy was performed in 2020 compared with 2019.

Conclusion: Many patients had significant delays in receiving gynecologic surgical care during the peak pandemic period. Further studies are indicated to determine the impact of delayed care on patients' quality of life and disease process.

背景与目的:2019冠状病毒病大流行严重影响妇科手术。2020年3月,美国外科医师学会建议推迟所有非必要的侵入性手术。本研究描述了在大流行高峰期间进行的手术的数量和类型。方法:采用回顾性队列研究。对2019年3月16日至2019年7月31日和2020年3月16日至2020年7月31日在某大型学术医院系统接受妇科手术的患者进行评估。根据州和医院政策的变化,按三个时间段对数据进行分层。在第1期间,没有建议采取不必要的程序。在第2期间,恢复了紧急程序。在第3期,完全手术重开。结果:2019年妇科手术1545例,2020年942例,下降39.0%。第一期病例减少73.6%,第二期减少20.1%,第3期增加2.9%。2020年妇科肿瘤科医师所做的病例占第一阶段所有妇科病例的58.1%,占第二阶段病例的29.4%,占第三阶段病例的33.3%。2020年,子宫切除术是最常见的手术,而子宫内膜异位症和子宫肌瘤的手术量减少幅度最大。在紧急手术中,与2019年相比,2020年进行了更多的异位妊娠手术。结论:在大流行高峰期,许多患者接受妇科手术治疗有明显延误。需要进一步的研究来确定延迟护理对患者生活质量和疾病进程的影响。
{"title":"Analysis of COVID-19 Response and Impact on Gynecologic Surgery at a Large Academic Hospital System.","authors":"Shabnam Gupta,&nbsp;Parmida Maghsoudlou,&nbsp;Mobolaji Ajao,&nbsp;Jon Ivar Einarsson,&nbsp;Louise Perkins King","doi":"10.4293/JSLS.2021.00056","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00056","url":null,"abstract":"<p><strong>Background and objectives: </strong>The COVID-19 pandemic dramatically impacted gynecologic surgery. In March 2020, the American College of Surgeons recommended delay of all nonessential invasive procedures. This study characterizes the number and types of procedures performed during the peak pandemic.</p><p><strong>Methods: </strong>A retrospective cohort study was performed. All patients undergoing gynecological surgery at a large academic hospital system from March 16, 2019 to July 31, 2019 and from March 16, 2020 to July 31, 2020 were evaluated. Data was stratified by three time periods corresponding to state and hospital policy changes. During period 1, no nonessential procedures were advised. During period 2, urgent procedures resumed. During period 3, full surgical reopening was achieved.</p><p><strong>Results: </strong>In 2019, 1,545 gynecologic cases were performed compared with 942 cases in 2020 (39.0% decrease). There was a 73.6% decrease in cases over period 1, a 20.1% decrease over period 2, and a 2.9% increase over period 3. Cases performed by gynecologic oncologists in 2020 accounted for 58.1% of all gynecologic cases over period 1, 29.4% of cases over period 2, and 33.3% of cases over period 3. In 2020, hysterectomy was the most commonly performed procedure, while surgery for endometriosis and uterine fibroids had the greatest decrease in volume. Among emergency procedures, more surgery for ectopic pregnancy was performed in 2020 compared with 2019.</p><p><strong>Conclusion: </strong>Many patients had significant delays in receiving gynecologic surgical care during the peak pandemic period. Further studies are indicated to determine the impact of delayed care on patients' quality of life and disease process.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/47/e2021.00056.PMC8580165.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39642922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
5G Use in Healthcare: The Future is Present. 5G在医疗保健中的应用:未来就是现在。
IF 1.5 4区 医学 Q2 Medicine Pub Date : 2021-10-01 DOI: 10.4293/JSLS.2021.00064
Konstantinos E Georgiou, Evangelos Georgiou, Richard M Satava

Background: Most healthcare providers are unaware of the extraordinary opportunities for implementation in healthcare which can be enabled by 5G wireless networks. 5G created enormous opportunities for a myriad of new technologies, resulting in an integrated through 5G 'ecosystem'. Although the new opportunities in healthcare are immense, medicine is slow to change, as manifest by the paucity of new, innovative applications based upon this ecosystem. Thus, emerges the need to "avoid technology surprise" - both laparoscopic and robotic assisted minimally invasive surgery were delayed for years because the surgical community was either unaware or unaccepting of a new technology.

Database: PubMed (Medline) and Scopus (Elsevier) databases were searched and all published studies regarding clinical applications of 5G were retrieved. From a total of 40 articles, 13 were finally included in our review.

Discussion: The important transformational properties of 5G communications and other innovative technologies are described and compared to healthcare needs, looking for opportunities, limitations, and challenges to implementation of 5G and the ecosystem it has spawned. Furthermore, the needs in the clinical applications, education and research in medicine and surgery, in addition to the administrative infrastructure are addressed. Additionally, we explore the nontechnical challenges, that either support or oppose this new healthcare renovation. Based upon proven advantages of these innovative technologies, current scientific evidence is analyzed for future trends for the transformation of healthcare. By providing awareness of these opportunities and their advantages for patients, it will be possible to decrease the prolonged timeframe for acceptance and implementation for patients.

背景:大多数医疗保健提供者都没有意识到5G无线网络可以在医疗保健领域实现的非凡机会。5G为无数新技术创造了巨大的机会,从而形成了一个通过5G整合的“生态系统”。尽管医疗保健领域的新机会巨大,但医学的变化却很缓慢,基于这一生态系统的创新应用程序的缺乏就体现了这一点。因此,出现了“避免技术意外”的需要——腹腔镜和机器人辅助的微创手术都被推迟了好几年,因为外科社区要么不知道,要么不接受一项新技术。数据库:检索PubMed (Medline)和Scopus (Elsevier)数据库,检索所有已发表的有关5G临床应用的研究。从总共40篇文章中,有13篇最终被纳入我们的综述。讨论:描述5G通信和其他创新技术的重要转型特性,并将其与医疗保健需求进行比较,寻找5G实施及其产生的生态系统的机遇、限制和挑战。此外,除了行政基础设施外,还解决了临床应用、医学和外科教育和研究方面的需要。此外,我们还探讨了支持或反对这种新的医疗保健改革的非技术挑战。基于这些创新技术已证实的优势,分析了当前的科学证据,以确定医疗保健转型的未来趋势。通过让患者意识到这些机会及其优势,将有可能缩短患者接受和实施的漫长时间。
{"title":"5G Use in Healthcare: The Future is Present.","authors":"Konstantinos E Georgiou,&nbsp;Evangelos Georgiou,&nbsp;Richard M Satava","doi":"10.4293/JSLS.2021.00064","DOIUrl":"https://doi.org/10.4293/JSLS.2021.00064","url":null,"abstract":"<p><strong>Background: </strong>Most healthcare providers are unaware of the extraordinary opportunities for implementation in healthcare which can be enabled by 5G wireless networks. 5G created enormous opportunities for a myriad of new technologies, resulting in an integrated through 5G 'ecosystem'. Although the new opportunities in healthcare are immense, medicine is slow to change, as manifest by the paucity of new, innovative applications based upon this ecosystem. Thus, emerges the need to \"avoid technology surprise\" - both laparoscopic and robotic assisted minimally invasive surgery were delayed for years because the surgical community was either unaware or unaccepting of a new technology.</p><p><strong>Database: </strong>PubMed (Medline) and Scopus (Elsevier) databases were searched and all published studies regarding clinical applications of 5G were retrieved. From a total of 40 articles, 13 were finally included in our review.</p><p><strong>Discussion: </strong>The important transformational properties of 5G communications and other innovative technologies are described and compared to healthcare needs, looking for opportunities, limitations, and challenges to implementation of 5G and the ecosystem it has spawned. Furthermore, the needs in the clinical applications, education and research in medicine and surgery, in addition to the administrative infrastructure are addressed. Additionally, we explore the nontechnical challenges, that either support or oppose this new healthcare renovation. Based upon proven advantages of these innovative technologies, current scientific evidence is analyzed for future trends for the transformation of healthcare. By providing awareness of these opportunities and their advantages for patients, it will be possible to decrease the prolonged timeframe for acceptance and implementation for patients.</p>","PeriodicalId":17679,"journal":{"name":"JSLS : Journal of the Society of Laparoendoscopic Surgeons","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/e7/e2021.00064.PMC8764898.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39866370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
期刊
JSLS : Journal of the Society of Laparoendoscopic Surgeons
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1